FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Through my understanding of sleep physiology and the latest scientific research, I have dramatically improved my sleep. I use ...
Md. - CuriosityStream Inc. (NASDAQ:CURI), a global factual entertainment company, has raised its upcoming dividend by 20%, bringing the yield to 4.59%, signaling confidence in its financial ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Some Democrats are playing political games and are pushing back against President Donald Trump's deportation raids that are sweeping up violent criminals across the country.